Pembrolizumab Monoclonal Antibody from Canada
Pembrolizumab (Keytruda) is a humanized IgG4 monoclonal antibody blocking PD-1 for immunotherapy in melanoma and lung cancer. HTS 3002.13.0010 for unmixed biotech monoclonal antibodies regulating immunology. Supplied in bulk, non-retail.
Duty Rate — Canada → United States
100%
Rate breakdown
9903.04.60100%Pharmaceuticals: patented pharma articles — 100% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Align with FDA's RPDR for real-time import status tracking
• Include ADCC assay data for potency verification